Remsima®

ACTIVE PRINCIPLE:
Infliximab

INDICATION:
Rheumatoid Arthritis
Crohn's disease
Ulcerative colitis
Ankylosing spondylitis
Psoriasic arthritis
Psoriasis

DATE:
23/06/2014

STATUS:
Authorized

MORE INFORMATION